share_log

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Nanis Nikolaos P.

Teladoc Health | 4: Statement of changes in beneficial ownership of securities

Teladoc Health | 4：持股變動聲明
SEC announcement ·  04/04 04:09
牛牛AI助理已提取核心訊息
Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, Inc. (TDOC), completed a sale of 461 shares of common stock on April 2, 2024. The transaction was executed at a price of $14.314 per share, resulting in a total sale value of $6,598.75. Prior to this sale, Nanis exercised options to acquire 1,232 shares on April 1, 2024. Following these transactions, Nanis holds a total of 70,621 shares in the company. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security, both involving direct ownership.
Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, Inc. (TDOC), completed a sale of 461 shares of common stock on April 2, 2024. The transaction was executed at a price of $14.314 per share, resulting in a total sale value of $6,598.75. Prior to this sale, Nanis exercised options to acquire 1,232 shares on April 1, 2024. Following these transactions, Nanis holds a total of 70,621 shares in the company. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security, both involving direct ownership.
Teladoc Health, Inc.（TDOC）首席技術官尼古拉斯·納尼斯於2024年4月2日完成了461股普通股的出售。該交易以每股14.314美元的價格執行，總銷售價值爲6,598.75美元。在此次出售之前，納尼斯於2024年4月1日行使了期權收購了1,232股股票。在這些交易之後，納尼斯共持有該公司70,621股股份。此次出售以公開市場或私人銷售的形式進行，而收購是由於行使或轉換衍生證券，兩者都涉及直接所有權。
Teladoc Health, Inc.（TDOC）首席技術官尼古拉斯·納尼斯於2024年4月2日完成了461股普通股的出售。該交易以每股14.314美元的價格執行，總銷售價值爲6,598.75美元。在此次出售之前，納尼斯於2024年4月1日行使了期權收購了1,232股股票。在這些交易之後，納尼斯共持有該公司70,621股股份。此次出售以公開市場或私人銷售的形式進行，而收購是由於行使或轉換衍生證券，兩者都涉及直接所有權。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。